{
    "Symbol": "VRTX",
    "AssetType": "Common Stock",
    "Name": "Vertex Pharmaceuticals Inc",
    "Description": "Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.",
    "CIK": "875320",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "50 NORTHERN AVENUE, BOSTON, MA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "130518041000",
    "EBITDA": "4583700000",
    "PERatio": "32.84",
    "PEGRatio": "0.534",
    "BookValue": "71.8",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "15.4",
    "RevenuePerShareTTM": "39.49",
    "ProfitMargin": "0.395",
    "OperatingMarginTTM": "0.452",
    "ReturnOnAssetsTTM": "0.128",
    "ReturnOnEquityTTM": "0.244",
    "RevenueTTM": "10185000000",
    "GrossProfitTTM": "5323100000",
    "DilutedEPSTTM": "15.4",
    "QuarterlyEarningsGrowthYOY": "0.565",
    "QuarterlyRevenueGrowthYOY": "0.133",
    "AnalystTargetPrice": "486.45",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "13",
    "AnalystRatingHold": "8",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "32.84",
    "ForwardPE": "24.33",
    "PriceToSalesRatioTTM": "10.38",
    "PriceToBookRatio": "5.83",
    "EVToRevenue": "9.33",
    "EVToEBITDA": "20.0",
    "Beta": "0.392",
    "52WeekHigh": "510.64",
    "52WeekLow": "340.68",
    "50DayMovingAverage": "477.42",
    "200DayMovingAverage": "420.34",
    "SharesOutstanding": "258053000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}